Sticking with the biotech sector, cancer-focused biopharmaceutical company Galena Biopharma Inc (NASDAQ:GALE) gained 16.4% after announcing the first enrollment of a patient in its phase 2 clinical trials for immunotherapy GALE-301. Galena Biopharma Inc (NASDAQ:GALE) stock opened at $5.52 in last session, and closed at $6.24, while the day range of GALE stock is $5.50 – $6.84. The stock showed a positive weekly performance of 25.81%.
Arca Biopharma Inc (NASDAQ:ABIO) climbed 20% as it has been informed by Laboratory Corporation of America (LabCorp®) (NYSE: LH) that the U.S. Food and Drug Administration (FDA) has accepted LabCorp’s Investigational Device Exemption (IDE) application for the planned companion diagnostic test for GencaroTM (bucindolol hydrochloride), a pharmacologically unique beta-blocker and mild vasodilator being developed for atrial fibrillation (AF). Arca Biopharma Inc (NASDAQ:ABIO) stock opened at $2.20, in last session and closed at $2.26, by gaining 25.56%. The 52 week range of the stock is $1.13 – $5.93. Company’s market capitalization is $35.43 billion.
Zalicus Inc (NASDAQ:ZLCS) gained 8.93% and the stock is quickly moving within range of triggering a major breakout trade after being destroyed by the bears over the last three months, with shares down by a whopping 81%. Zalicus Inc (NASDAQ:ZLCS) stock advanced 34.85% and finished the last session at $1.78. The EPS of the stock remained -1.72. Company’s market capitalization is $46.44 billion.
MannKind Corporation (Nasdaq:MNKD), focused on discovering, developing and commercializing treatments for diabetes, announced today that it will present at the J.P. Morgan 2014 Healthcare Conference on Wednesday, January 15, 2014 at 7:30 AM (PST) at Westin St. Francis Hotel in San Francisco, California. MannKind Corporation (NASDAQ:MNKD) stock opened the session at $5.50, and closed the session at $5.98. The 52 week range of the stock remained $2.34 – $8.70 and the day range was $5.39 – $5.99.
Leave a Reply